{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:27:30Z","timestamp":1776079650297,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.cgh.2011.05.020","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:43:29Z","timestamp":1307925809000},"page":"762-768.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Angel","family":"Lanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2011.05.020_bib1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_bib2","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2337\/dc09-1297","article-title":"Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes","volume":"32","author":"Calvin","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2011.05.020_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2011.05.020_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cgh.2011.05.020_bib6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-150-6-200903170-00009","article-title":"Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force","volume":"150","author":"Wolff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"4","author":"Garc\u00eda","year":"2006","journal-title":"BMC Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2011.05.020_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1472-8206.2008.00582.x","article-title":"Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients","volume":"22","author":"Serebruany","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cgh.2011.05.020_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/DHPS.S4334","article-title":"Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors","volume":"1","author":"Roston","year":"2009","journal-title":"Drugs Healthc Patient Saf"},{"key":"10.1016\/j.cgh.2011.05.020_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1164\/ajrccm.163.2.2006067","article-title":"Agreement between alternative classifications of acute respiratory distress syndrome","volume":"163","author":"Meade","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cgh.2011.05.020_bib15","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1001\/jama.283.21.2829","article-title":"Users' guides to the medical literature: XX","volume":"283","author":"McAlister","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2011.05.020_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2011.05.020_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1745-6215-10-86","article-title":"Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison","volume":"10","author":"O'Regan","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.cgh.2011.05.020_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib20","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib21","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bmj.330.7501.1175","article-title":"Systematic review to determine whether participation in a trial influences outcome","volume":"330","author":"Vist","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2011.05.020_bib23","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable?","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2011.05.020_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2007.11.057","article-title":"Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events","volume":"101","author":"Bowry","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjmed.2009.08.016","article-title":"Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction","volume":"123","author":"Haq","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analyses\u2014sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2011.05.020_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","article-title":"Validity of composite end points in clinical trials","volume":"330","author":"Montori","year":"2005","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2011.05.020_bib28","first-page":"S37","article-title":"Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding","volume":"31","author":"Lanas","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2011.05.020_bib29","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1590-8658(01)80156-0","article-title":"Cyclo-oxygenase-1\/cyclo-oxygenase-2 non selective non-steroidal anti-inflammatory drugs: epidemiology of gastrointestinal events","volume":"33","author":"Lanas","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2011.05.020_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00042737-200106000-00001","article-title":"Nonsteroidal anti-inflammatory drugs, low-dose aspirin, and potential ways of reducing the risk of complications","volume":"13","author":"Lanas","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2011.05.020_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"Lanas","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2011.05.020_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2011.05.020_fr1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(99)00598-7","article-title":"Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical prosthesis: a clinical and transesophageal echocardiographic study","volume":"35","author":"Laffort","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_fr2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5223(97)70264-2","article-title":"Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves","volume":"113","author":"Meschengieser","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cgh.2011.05.020_fr3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-123-9-199511010-00002","article-title":"Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing","volume":"123","author":"C\u00f4t\u00e9","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.296.6618.316","article-title":"United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results","volume":"296","year":"1988","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.cgh.2011.05.020_fr5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/clpt.1993.115","article-title":"Adverse effects of low-dose aspirin in a healthy elderly population","volume":"54","author":"Silagy","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2011.05.020_fr6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1532-5415.2009.02217.x","article-title":"Vascular care in patients with Alzheimer's disease with cerebrovascular lesions\u2014a randomized clinical trial","volume":"57","author":"Richard","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cgh.2011.05.020_fr7","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2011.05.020_fr8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.urology.2007.04.016","article-title":"Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial","volume":"70","author":"Giannarini","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.cgh.2011.05.020_fr9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.CIR.82.3.765","article-title":"Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole","volume":"82","author":"Sanz","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in atrial fibrillation III randomised clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1474-4422(07)70293-4","article-title":"Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial","volume":"7","author":"Bentham","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cgh.2011.05.020_fr16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"Catalano","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","article-title":"Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation","volume":"12","author":"Lechat","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.cgh.2011.05.020_fr21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000070420","article-title":"Effect of low-dose aspirin on the international normalized ratio variability in patients with mechanical heart valve prostheses","volume":"32","author":"Casais","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.cgh.2011.05.020_fr24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice","volume":"357","author":"de Gaetano","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr25","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.cgh.2011.05.020_fr26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.CIR.83.5.1526","article-title":"Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery","volume":"83","author":"Gavaghan","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","article-title":"Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris","volume":"340","author":"Juul-M\u00f6ller","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2011.05.020_fr31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom Heart and Renal Protection","volume":"45","author":"Baigent","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2011.05.020_fr32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5694\/j.1326-5377.1993.tb137909.x","article-title":"Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients","volume":"159","author":"Hockings","year":"1993","journal-title":"Med J Aust"},{"key":"10.1016\/j.cgh.2011.05.020_fr34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cgh.2011.05.020_fr35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr37","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr38","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)01180-X","article-title":"Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr40","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.103.13.1727","article-title":"Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes","volume":"103","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.98.11.1064","article-title":"Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results","volume":"98","author":"Anand","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000024408.81821.32","article-title":"Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 trial","volume":"106","author":"Brouwer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group)","volume":"66","author":"Cohen","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_fr44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","article-title":"Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study","volume":"105","author":"Fiore","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr46","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinte.159.12.1322","article-title":"Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study","volume":"159","author":"Gullov","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ehj.2003.10.026","article-title":"Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA study","volume":"25","author":"Herlitz","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cgh.2011.05.020_fr48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr49","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1161\/01.CIR.103.25.3069","article-title":"Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery","volume":"103","author":"Huynh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2011.05.020_fr50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2310\/6670.2004.00043","article-title":"Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery","volume":"12","author":"Johnson","year":"2004","journal-title":"Vascular"},{"key":"10.1016\/j.cgh.2011.05.020_fr51","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing 3 antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cgh.2011.05.020_fr53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomized controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2011.05.020_fr54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0735-1097(97)00153-8","article-title":"Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study","volume":"30","author":"Williams","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_fr55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/000331970405500103","article-title":"Warfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot study","volume":"55","author":"Zibaeenezhad","year":"2004","journal-title":"Angiology"},{"key":"10.1016\/j.cgh.2011.05.020_fr56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0735-1097(00)01118-9","article-title":"Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina","volume":"37","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2011.05.020_fr57","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr58","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2011.05.020_fr59","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356511005623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356511005623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:07:51Z","timestamp":1761541671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356511005623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1542356511005623"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2011.05.020","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2011.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}